Market overview
The global softgel capsule market is worth USD 9.6 bn in 2026 and is forecast to reach USD 18.2 bn by 2036, growing at a 6.6% CAGR. United States is the largest country market and Gelatin is the largest by shell segment.
| Scope | Softgel capsules with a soft gelatin or plant-based shell and liquid or semi-solid fill, for vitamins, fish oil, cannabinoids and prescription drugs. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 9.0 bn |
| Value 2026 | USD 9.6 bn |
| Value 2036 | USD 18.2 bn |
| CAGR 2026-2036 | 6.6% |
| Volume 2026 | 237,723 million pieces |
| Volume 2036 | 415,947 million pieces |
| Average price 2026 | USD 0.04 per piece |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Softgel Capsule market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 9.6 bn |
| 2027 | USD 10.2 bn |
| 2028 | USD 10.9 bn |
| 2029 | USD 11.6 bn |
| 2030 | USD 12.4 bn |
| 2031 | USD 13.2 bn |
| 2032 | USD 14.1 bn |
| 2033 | USD 15.0 bn |
| 2034 | USD 16.0 bn |
| 2035 | USD 17.0 bn |
| 2036 | USD 18.2 bn |
Softgel Capsule market segmentation
By shell
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Gelatin | 70.0% | 59.4% | USD 6.7 bn | 4.9% |
| Plant-based and starch | 20.0% | 30.2% | USD 1.9 bn | 11.1% |
| Other shells | 10.0% | 10.4% | USD 958 mn | 7.1% |
By application
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Dietary supplements | 48.0% | 50.2% | USD 4.6 bn | 7.1% |
| Prescription pharmaceuticals | 22.0% | 20.9% | USD 2.1 bn | 6.1% |
| Over-the-counter medicines | 18.0% | 16.3% | USD 1.7 bn | 5.6% |
| Cosmetics and other | 12.0% | 12.5% | USD 1.2 bn | 7.1% |
By fill
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Oil and lipid | 60.0% | 57.0% | USD 5.8 bn | 6.0% |
| Suspension and semi-solid | 26.0% | 28.4% | USD 2.5 bn | 7.5% |
| Other solutions | 14.0% | 14.6% | USD 1.3 bn | 7.0% |
By dose type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Single-active | 56.0% | 52.0% | USD 5.4 bn | 5.8% |
| Multi-active and combination | 30.0% | 32.0% | USD 2.9 bn | 7.3% |
| High-strength and specialty | 14.0% | 16.0% | USD 1.3 bn | 8.0% |
By functional use
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Nutritional supplements | 42.0% | 42.0% | USD 4.0 bn | 6.6% |
| Therapeutic drugs | 28.0% | 26.0% | USD 2.7 bn | 5.8% |
| Cosmetic and personal care | 12.0% | 13.0% | USD 1.2 bn | 7.5% |
| Veterinary and pet supplements | 18.0% | 19.0% | USD 1.7 bn | 7.2% |
Top 25 countries for softgel capsule by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 78.0% of 2026 revenue and the 25 countries below together hold 93.4%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 2.7 bn | 28.0% | USD 4.8 bn | 6.0% |
| 2 | China | USD 1.2 bn | 12.0% | USD 2.6 bn | 8.5% |
| 3 | Japan | USD 767 mn | 8.0% | USD 1.2 bn | 4.6% |
| 4 | Germany | USD 575 mn | 6.0% | USD 944 mn | 5.1% |
| 5 | India | USD 575 mn | 6.0% | USD 1.5 bn | 10.0% |
| 6 | Brazil | USD 431 mn | 4.5% | USD 854 mn | 7.1% |
| 7 | United Kingdom | USD 383 mn | 4.0% | USD 654 mn | 5.5% |
| 8 | France | USD 335 mn | 3.5% | USD 545 mn | 5.0% |
| 9 | Canada | USD 288 mn | 3.0% | USD 509 mn | 5.9% |
| 10 | Australia | USD 288 mn | 3.0% | USD 545 mn | 6.6% |
| 11 | Mexico | USD 279 mn | 2.9% | USD 529 mn | 6.6% |
| 12 | Spain | USD 203 mn | 2.1% | USD 343 mn | 5.4% |
| 13 | Russia | USD 150 mn | 1.6% | USD 252 mn | 5.3% |
| 14 | Netherlands | USD 121 mn | 1.3% | USD 203 mn | 5.3% |
| 15 | Switzerland | USD 103 mn | 1.1% | USD 173 mn | 5.3% |
| 16 | Thailand | USD 89 mn | 0.9% | USD 214 mn | 9.2% |
| 17 | Indonesia | USD 80 mn | 0.8% | USD 191 mn | 9.1% |
| 18 | Turkey | USD 72 mn | 0.8% | USD 173 mn | 9.2% |
| 19 | Poland | USD 66 mn | 0.7% | USD 158 mn | 9.1% |
| 20 | South Korea | USD 61 mn | 0.6% | USD 104 mn | 5.4% |
| 21 | Vietnam | USD 57 mn | 0.6% | USD 136 mn | 9.2% |
| 22 | Argentina | USD 53 mn | 0.6% | USD 127 mn | 9.2% |
| 23 | Saudi Arabia | USD 50 mn | 0.5% | USD 120 mn | 9.2% |
| 24 | Italy | USD 47 mn | 0.5% | USD 80 mn | 5.5% |
| 25 | Belgium | USD 45 mn | 0.5% | USD 76 mn | 5.4% |
| Rest of world | USD 634 mn | 6.6% | USD 1.1 bn | 6.0% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Catalent
- Lonza
- Aenova
- Procaps Group
- Thermo Fisher Scientific
Group 2: Regional and specialist players
- Sirio Pharma
- Captek Softgel
- Softigel
- Strides Pharma
- Soft Gel Technologies
- EuroCaps
- Fuji Capsule
- Suheung
- CapsCanada
Group 3: Emerging and niche players
- ProCaps Laboratories
- Sunsho Pharmaceutical
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the softgel capsule market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.6% is calculated from the resulting values.
The market is divided by shell, by application, by fill, by dose type, by functional use. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the softgel capsule market?
The global softgel capsule market is estimated at USD 9.0 bn in 2025 and USD 9.6 bn in 2026.
How fast will the softgel capsule market grow?
It is forecast to reach USD 18.2 bn by 2036, a compound annual growth rate of 6.6% from 2026, an increase of USD 8.6 bn.
Which country is the largest market for softgel capsule?
United States is the largest market by revenue at USD 2.7 bn in 2026, 28.0% of the global total. The three largest countries together hold 48.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 10.0% a year from 2026 to 2036.
Which softgel capsule segment is largest?
In the by shell split, Gelatin is the largest segment with 70.0% of 2026 revenue.
Who are the leading softgel capsule companies?
Global leaders include Catalent, Lonza, Aenova, Procaps Group.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- VialUSD 9.7 bn · 7.5% CAGR
- Cell TherapyUSD 9.4 bn · 20.0% CAGR
- Protein PurificationUSD 9.3 bn · 9.0% CAGR
- Lateral Flow AssayUSD 10.0 bn · 5.0% CAGR
- Pharmaceutical ExcipientsUSD 10.1 bn · 6.5% CAGR
- Pharmaceutical LabelingUSD 9.0 bn · 5.8% CAGR
- FermentationUSD 10.3 bn · 8.5% CAGR
- Filtration MembraneUSD 10.3 bn · 8.5% CAGR